PACB Pacific Biosciences of California, Inc.

PACB Pacific Biosciences of California, Inc.

Healthcare · Medical Devices

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-23 1 bull converging

POC $1.32 · VWAP $1.82 · +15.8% vs 12m avg buyer

pullback vol: expandinggaps: overnight-shiftchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @biotech-capital-cycle@ibb

PACB Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist PACB belongs to, members best 30-day change first — PACB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
NAUT+239.7% +24.6%1d +57.3%7d QSI+84.5% +21.7%1d +25.0%7d PACB+49.6% +2.4%1d +22.0%7d CRL+24.5% +1.7%1d +15.1%7d FTRE+21.1% -1.2%1d +5.1%7d CERT+19.6% +2.4%1d +10.3%7d AVTR+17.1% +0.8%1d +5.3%7d DNA+16.4% +2.9%1d -2.7%7d ICLR+13.0% -0.1%1d +8.9%7d MTD+11.9% -0.8%1d +3.0%7d RVTY+11.7% +0.9%1d +4.0%7d SEER+9.4% 0.0%1d -3.0%7d MEDP+8.4% +2.3%1d +8.2%7d AGIO+8.2% -0.5%1d +18.1%7d WAT+7.9% -0.4%1d +3.8%7d ILMN+5.5% 0.0%1d +2.6%7d A+4.7% -0.5%1d +0.1%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d TMO+1.3% -0.4%1d -2.3%7d RXRX0.0% +3.4%1d +6.6%7d BRKR-3.5% +0.5%1d +5.1%7d XBI-3.6% -1.4%1d +3.6%7d ABCL-4.0% +4.0%1d +0.2%7d RGEN-4.1% -1.0%1d +0.9%7d ALMR-4.5% +3.3%1d +21.4%7d TXG-5.4% +2.6%1d +2.4%7d ABSI-5.8% -2.0%1d +11.3%7d CDXS-7.3% -2.3%1d +3.2%7d QTRX-9.5% +0.7%1d -0.3%7d TEM-11.7% +6.0%1d +4.5%7d TWST-11.7% +3.3%1d +5.4%7d LAB-18.4% -4.7%1d -3.7%7d SDGR-18.6% +5.3%1d +5.3%7d GENB-24.9% -3.0%1d +2.6%7d VKTX-41.4% -5.5%1d -3.1%7d
@ibb
View watchlist →
PACB+49.6% +2.4%1d +22.0%7d ICLR+13.0% -0.1%1d +8.9%7d BIIB+10.2% -1.2%1d +7.8%7d MRNA+9.9% -1.3%1d -8.2%7d MEDP+8.4% +2.3%1d +8.2%7d AMGN+8.2% -1.8%1d +1.6%7d ILMN+5.5% 0.0%1d +2.6%7d RARE+5.2% -1.9%1d +7.6%7d LEGN+4.4% +2.0%1d +4.3%7d NTRA+3.4% +0.6%1d +2.7%7d GILD+3.1% -0.7%1d -0.1%7d VRTX+1.5% -2.1%1d +4.8%7d REGN+0.4% -1.7%1d +1.8%7d PTGX-0.2% -0.8%1d +7.5%7d COGT-0.6% -0.3%1d +5.7%7d BEAM-1.3% -2.1%1d +2.5%7d RVMD-2.0% -0.4%1d +5.1%7d IONS-2.3% -2.2%1d 0.0%7d ABCL-4.0% +4.0%1d +0.2%7d KYMR-4.1% -0.1%1d +5.7%7d IBRX-4.8% -1.1%1d -10.5%7d TXG-5.4% +2.6%1d +2.4%7d ABSI-5.8% -2.0%1d +11.3%7d SRPT-6.4% -2.5%1d +3.7%7d INCY-7.2% -1.0%1d +2.3%7d ARGX-7.6% -0.2%1d +6.7%7d NTLA-9.1% +0.5%1d -1.8%7d ALNY-9.1% -1.4%1d -3.4%7d QTRX-9.5% +0.7%1d -0.3%7d BMRNE-10.1% -1.2%1d +2.3%7d BNTX-10.5% -1.7%1d +0.5%7d EDIT-10.8% -3.6%1d +2.1%7d CRSP-11.4% -1.2%1d +0.3%7d TWST-11.7% +3.3%1d +5.4%7d TEM-11.7% +6.0%1d +4.5%7d SDGR-18.6% +5.3%1d +5.3%7d NKTR-35.5% -3.7%1d +4.0%7d

Next earnings PACB reports in 12 days Nov 4

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $39M, diluted EPS -$0.14, net income -$45M (SEC filing). Across the print the stock moved -18.8% (close before → first close after).

full note →

Against street estimates

How PACB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Oct 23

Result
Aug 5 -0.13-0.14-10.4%Miss
May 7 -0.13-0.12+8.7%Beat
Feb 12 -0.13-0.12+10.8%Beat
Nov 5 '25 -0.14-0.12+15.1%Beat
Aug 7 '25 -0.17-0.13+21.5%Beat
May 8 '25 -0.19-0.15 GAAP ≠ +20.5%Beat
Feb 13 '25 -0.17-0.20-15.5%Miss
Nov 7 '24 -0.21-0.17+20.1%Beat

Recent news

Headlines about PACB from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 22

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

PACB research tape

19 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Monster Scan — 2026-10-23 scan Monster Scan — 2026-10-21 brief OpenAI's Smaller Number Hits Every Layer of AI Hardware; SpaceX Hits the Carriers After the... brief Megacaps Carry the Nasdaq to a Record While the Compute Landlords Sell brief The Suppliers Ran, the Neoclouds Sat, and the 10-Year Hit a 24-Year High
Types
Oct 23 Scan Monster Scan
005930.KS009150.KS1888.HK2308.TW2383.TW2449.TW2802.T3037.TWE +4 more
Oct 21 Scan Monster Scan
005930.KS009150.KS1888.HK2308.TW2383.TW2449.TW2802.T3037.TWE +4 more
Oct 8 Market Brief OpenAI's Smaller Number Hits Every Layer of AI Hardware; SpaceX Hits the Carriers After the Bell
ABBNYABCLABSIAPLEATH.TOGCTPBFHAE +4 more
Oct 5 Market Brief Megacaps Carry the Nasdaq to a Record While the Compute Landlords Sell
ADMAMCAPAARGXAVAX-USDPCVXDNARXRX +4 more
Oct 1 Market Brief The Suppliers Ran, the Neoclouds Sat, and the 10-Year Hit a 24-Year High
ABBVAIRAMRASMLBAMBOXIDTCTVA +4 more
Sep 30 Market Brief Neoclouds Sell as One, Then Micron Says Memory Stays Short Through 2028
AKAMAPAAYABDRYBGBTDRMNDYLQDA +4 more
Sep 25 Scan Washout Turn Scan
AALAAONACLSAIAIPAKAMALNYAMKRE +4 more
Sep 24 Scan Washout Turn Scan
AAONAEISAIPAMKREAOSLBELFBBKKTBTDR +4 more
Sep 23 Scan Washout Turn Scan
AAONAEISAIAIPAMKREAOSLAPLDBKKT +4 more
Sep 22 Scan Washout Turn Scan
AIAIPALKALNYALTAMKREAOSLAPLD +4 more
Sep 18 Scan Washout Turn Scan
ADA-USDATENAVAX-USDBKKTCEPLCIFRCOINCONY +4 more
Sep 17 Scan Washout Turn Scan
ACNAGIAIAVAX-USDCIFRCLSECOINDGXX +4 more
Sep 16 Scan Washout Turn Scan
ACNAIAPPBAHCEHUBSPACBRBLX +4 more
Sep 15 Scan Washout Turn Scan
ACNAIAPPBAHCEHUBSIBMPACB +4 more
Sep 8 Scan Washout Turn Scan
AAUCADA-USDAGIALNYALTARMPAVAX-USDBITO +4 more
Aug 27 Scan Washout Turn Scan
AAAAUCACNADA-USDAGIAIALBALT +4 more
Aug 26 Scan Washout Turn Scan
AAUCADA-USDADBEAGIALBALTARMPAVAX-USD +4 more
Aug 25 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIALBALT +4 more
Aug 5 Catalyst PACB earnings
PACB